Patent: 6,093,398
✉ Email this page to a colleague
Summary for Patent: 6,093,398
| Title: | Medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction |
| Abstract: | The use of an MMP inhibitor, especially a collagenase inhibitor, in the manufacture of a medicament for the treatment of a natural or artificial tissue comprising extracellular matrix components to inhibit contraction of the tissue and methods for the treatment of tissue comprising extracellular matrix components to inhibit contraction. |
| Inventor(s): | Khaw; Peng Tee (London, GB), Schultz; Gregory S. (Gainesville, FL) |
| Assignee: | University of Florida Research Found (Gainesville, FL) Institute of Ophthalmology (London, GB) Moorfields Eye Hospital NHS Trust (London, GB) |
| Application Number: | 08/716,155 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,093,398
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | TRASYLOL | aprotinin | Injection | 020304 | 12/29/1993 | ⤷ Try a Trial | 2014-03-16 |
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2014-03-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
